Misoprostol

Drug

Drug Profile

Misoprostol is a prostaglandin analog medicine used for ulcer prevention and multiple obstetric/gynecologic indications, including abortion regimens and postpartum bleeding contexts. In U.S. products it is marketed as Cytotec and in combinations such as Arthrotec. It is available as an established prescription medicine.

Drug Class
Miscellaneous GI agent (prostaglandin analog)
Approval Status
Marketed prescription products are available in the United States.
Mechanism of Action
Inhibits gastric acid secretion in parietal cells and induces uterine contractions/cervical ripening.
Brand Names
  • Cytotec
  • Arthrotec
Indications
  • Abortion
  • \Cervical ripening\
  • \Labor induction\
  • \NSAID-induced ulcer prophylaxis\
  • \Postpartum bleeding\
  • \Duodenal/stomach ulcer\

Related News

Related Clinical Trials

NCT ID Title Status Phase
NCT07559812

Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy

ACTIVE_NOT_RECRUITING NA
NCT07416487

Comparison of Outcome of Foley Catheter Versus Misoprostol for Induction of Labor

COMPLETED NA
NCT07353281

Carbetocin vs Misoprostol for Postpartum Hemorrhage Prevention

NOT_YET_RECRUITING NA
NCT06946914

Misoprostol Before Caesarean Section

RECRUITING PHASE4
NCT06909721

Misoprostol Versus Dinoprostone in Induction of Labor

COMPLETED NA
NCT06850974

Foley Balloon for Cervical Preparation Before Dilation and Evacuation

RECRUITING NA
NCT06765473

Comparison Between Preoperative Vaginal and Postoperative Sublingual Misoprostol for Prevention of Postpartum Hemorrhage During Cesarean Section

NOT_YET_RECRUITING PHASE3
NCT06669533

Use Misoprostol to Optimize Prevention of Cervical Cancer

RECRUITING NA
NCT06502158

Mifepristone vs Misoprostol

RECRUITING PHASE1
NCT06452719

Letrozole and Misoprostol for Early Pregnancy Loss Management

RECRUITING PHASE2